J L Monstastruc < J L Montastruc < J L Renard

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 61.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
001003 (2003)	G. Fénelon [France] ; S. Giménez-Roldán ; J L Montastruc ; F. Bermejo ; F. Durif ; I. Bourdeix ; J-J Péré ; L. Galiano ; J. Schadrack	Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study.
001039 (2002)	O. Rascol [France] ; J J Ferreira ; P. Payoux ; Ch Brefel-Courbon ; J L Montastruc	[Management of levodopa-induced dyskinesia].
001109 (2001)	O. Rascol [France] ; J. Ferreira ; J L Montastruc	[Abnormal diurnal somnolence, "sleep attacks" and antiparkinson drugs].
001113 (2001)	O. Rascol [France] ; N. Fabre ; C. Brefel-Courbon ; J L Montastruc	The pharmacologic treatment of gait ignition failure.
001123 (2001)	J M Senard [France] ; C. Brefel-Courbon ; O. Rascol ; J L Montastruc	Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management.
001128 (2001)	J L Montastruc [France] ; K. Desboeuf ; M. Lapeyre-Mestre ; J M Senard ; O. Rascol ; C. Brefel-Courbon	Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
001136 (2001)	O. Rascol [France] ; I. Arnulf ; H. Peyro-Saint Paul ; C. Brefel-Courbon ; M. Vidailhet ; C. Thalamas ; A M Bonnet ; S. Descombes ; B. Bejjani ; N. Fabre ; J L Montastruc ; Yves Agid [France]	Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.
001147 (2001)	O. Rascol [France] ; J J Ferreira ; C. Thalamas ; M. Galitsky ; J L Montastruc	Dopamine agonists. Their role in the management of Parkinson's disease.
001159 (2000)	O. Rascol [France] ; J L Montastruc	[Role of dopaminergic agonists].
001239 (1999)	J L Montastruc [France] ; O. Rascol ; J M Senard	Treatment of Parkinson's disease should begin with a dopamine agonist.
001297 (1999)	O. Rascol [France] ; C. Brefel-Courbon ; S. Descombes ; J L Montastruc	Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients.
001309 (1999)	J L Montastruc [France] ; M. Ziegler ; O. Rascol ; M. Malbezin	A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease.
001331 (1998)	N. Fabre [France] ; C. Brefel ; U. Sabatini ; P. Celsis ; J L Montastruc ; F. Chollet ; O. Rascol	Normal frontal perfusion in patients with frozen gait.
001346 (1998)	J L Montastruc [France] ; M. Pelat ; P. Verwaerde ; C. Brefel-Courbon ; M A Tran ; O. Blin ; O. Rascol ; J M Senard	Fluoxetine in orthostatic hypotension of Parkinson's disease: a clinical and experimental pilot study.
001350 (1998)	C. Brefel [France] ; C. Thalamas ; S. Rayet ; A. Lopez-Gil ; K. Fitzpatrick ; S. Bullman ; D R Citerone ; A C Taylor ; J L Montastruc ; O. Rascol	Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients.
001354 (1998)	O. Rascol [France] ; U. Sabatini ; C. Brefel ; N. Fabre ; S. Rai ; J M Senard ; P. Celsis ; G. Viallard ; J L Montastruc ; F. Chollet	Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia.
001372 (1997)	O. Rascol [France] ; U. Sabatini ; N. Fabre ; C. Brefel ; I. Loubinoux ; P. Celsis ; J M Senard ; J L Montastruc ; F. Chollet	The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients.
001384 (1997)	J M Senard [France] ; S. Raï ; M. Lapeyre-Mestre ; C. Brefel ; O. Rascol ; A. Rascol ; J L Montastruc	Prevalence of orthostatic hypotension in Parkinson's disease.
001401 (1997)	J L Montastruc [France] ; O. Rascol ; J M Senard	Glutamate antagonists and Parkinson's disease: a review of clinical data.
001418 (1997)	N. Andreu [France] ; C. Damase-Michel ; J M Senard ; O. Rascol ; J L Montastruc	A dose-ranging study of selegiline in patients with Parkinson's disease: effect of platelet monoamine oxidase activity.
001429 (1996)	O. Rascol [France] ; A J Lees ; J M Senard ; Z. Pirtosek ; J L Montastruc ; D. Fuell	Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "J L Montastruc" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "J L Montastruc" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    J L Montastruc
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024